Lipolytic rate associated with intramyocardial lipid in an HIV cohort without increased lipolysis

Louisa C. Howard, Chia Ying Liu, Julia B. Purdy, Peter Walter, David A. Bluemke, Colleen Hadigan

Research output: Contribution to journalArticle

Abstract

Context: Individuals with HIV have an elevated risk for developing cardiovascular disease compared to controls, particularly in relationship to abnormal deposition of lipid within various body compartments. Dysregulation of lipolysis may contribute to abnormal deposition of lipid in nonadipose tissues such as the heart, leading to untoward health consequences. Objective: To evaluate potential relationships between rates of whole-body lipolysis and intramyocardial lipid content in HIV-infected subjects compared to healthy controls. Design: Cross-sectional study. Setting: National Institutes of Health Clinical Research Center in Bethesda, Maryland. Participants: Forty-six HIV-infected adults and 12 controls without known cardiovascular disease. Main Outcome Measure: Intramyocardial lipid content quantified by MRI and rates of lipolysis determined using stable isotope tracer techniques. Results:Weobserved a significant positive correlation between the rate of appearance of glycerol and intramyocardial lipid overall (r = 0.323; P = .014) and among the HIV group separately (r = 0.361; P = .014). Multivariate regression analyses including HIV, lipid-lowering therapy, and diabetes identified both rate of appearance of glycerol and age as independent significant predictors of intramyocardial lipid (P = .01 and P = .03, respectively), but these were not significant with inclusion of visceral adipose in the analyses. Conclusions: To our knowledge, this study is among the first in humans to characterize the relationship between lipid deposition in the myocardium and direct measurement of whole-body fatty acid metabolism. Our current findings contribute to the growing understanding of factors that promote myocardial steatosis, such as visceral adiposity, and implicate lipolysis as a potential target for interventions to optimize myocardial health.

Original languageEnglish (US)
Pages (from-to)151-156
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume101
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Lipolysis
HIV
Lipids
Health
Glycerol
Cardiovascular Diseases
Adiposity
National Institutes of Health (U.S.)
Medical problems
Metabolism
Isotopes
Magnetic resonance imaging
Myocardium
Fatty Acids
Multivariate Analysis
Cross-Sectional Studies
Regression Analysis
Outcome Assessment (Health Care)
Tissue
Research

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Lipolytic rate associated with intramyocardial lipid in an HIV cohort without increased lipolysis. / Howard, Louisa C.; Liu, Chia Ying; Purdy, Julia B.; Walter, Peter; Bluemke, David A.; Hadigan, Colleen.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 101, No. 1, 01.01.2016, p. 151-156.

Research output: Contribution to journalArticle

Howard, Louisa C. ; Liu, Chia Ying ; Purdy, Julia B. ; Walter, Peter ; Bluemke, David A. ; Hadigan, Colleen. / Lipolytic rate associated with intramyocardial lipid in an HIV cohort without increased lipolysis. In: Journal of Clinical Endocrinology and Metabolism. 2016 ; Vol. 101, No. 1. pp. 151-156.
@article{f175d660dcf744feba9d8f5cf6593b30,
title = "Lipolytic rate associated with intramyocardial lipid in an HIV cohort without increased lipolysis",
abstract = "Context: Individuals with HIV have an elevated risk for developing cardiovascular disease compared to controls, particularly in relationship to abnormal deposition of lipid within various body compartments. Dysregulation of lipolysis may contribute to abnormal deposition of lipid in nonadipose tissues such as the heart, leading to untoward health consequences. Objective: To evaluate potential relationships between rates of whole-body lipolysis and intramyocardial lipid content in HIV-infected subjects compared to healthy controls. Design: Cross-sectional study. Setting: National Institutes of Health Clinical Research Center in Bethesda, Maryland. Participants: Forty-six HIV-infected adults and 12 controls without known cardiovascular disease. Main Outcome Measure: Intramyocardial lipid content quantified by MRI and rates of lipolysis determined using stable isotope tracer techniques. Results:Weobserved a significant positive correlation between the rate of appearance of glycerol and intramyocardial lipid overall (r = 0.323; P = .014) and among the HIV group separately (r = 0.361; P = .014). Multivariate regression analyses including HIV, lipid-lowering therapy, and diabetes identified both rate of appearance of glycerol and age as independent significant predictors of intramyocardial lipid (P = .01 and P = .03, respectively), but these were not significant with inclusion of visceral adipose in the analyses. Conclusions: To our knowledge, this study is among the first in humans to characterize the relationship between lipid deposition in the myocardium and direct measurement of whole-body fatty acid metabolism. Our current findings contribute to the growing understanding of factors that promote myocardial steatosis, such as visceral adiposity, and implicate lipolysis as a potential target for interventions to optimize myocardial health.",
author = "Howard, {Louisa C.} and Liu, {Chia Ying} and Purdy, {Julia B.} and Peter Walter and Bluemke, {David A.} and Colleen Hadigan",
year = "2016",
month = "1",
day = "1",
doi = "10.1210/jc.2015-3058",
language = "English (US)",
volume = "101",
pages = "151--156",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Lipolytic rate associated with intramyocardial lipid in an HIV cohort without increased lipolysis

AU - Howard, Louisa C.

AU - Liu, Chia Ying

AU - Purdy, Julia B.

AU - Walter, Peter

AU - Bluemke, David A.

AU - Hadigan, Colleen

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Context: Individuals with HIV have an elevated risk for developing cardiovascular disease compared to controls, particularly in relationship to abnormal deposition of lipid within various body compartments. Dysregulation of lipolysis may contribute to abnormal deposition of lipid in nonadipose tissues such as the heart, leading to untoward health consequences. Objective: To evaluate potential relationships between rates of whole-body lipolysis and intramyocardial lipid content in HIV-infected subjects compared to healthy controls. Design: Cross-sectional study. Setting: National Institutes of Health Clinical Research Center in Bethesda, Maryland. Participants: Forty-six HIV-infected adults and 12 controls without known cardiovascular disease. Main Outcome Measure: Intramyocardial lipid content quantified by MRI and rates of lipolysis determined using stable isotope tracer techniques. Results:Weobserved a significant positive correlation between the rate of appearance of glycerol and intramyocardial lipid overall (r = 0.323; P = .014) and among the HIV group separately (r = 0.361; P = .014). Multivariate regression analyses including HIV, lipid-lowering therapy, and diabetes identified both rate of appearance of glycerol and age as independent significant predictors of intramyocardial lipid (P = .01 and P = .03, respectively), but these were not significant with inclusion of visceral adipose in the analyses. Conclusions: To our knowledge, this study is among the first in humans to characterize the relationship between lipid deposition in the myocardium and direct measurement of whole-body fatty acid metabolism. Our current findings contribute to the growing understanding of factors that promote myocardial steatosis, such as visceral adiposity, and implicate lipolysis as a potential target for interventions to optimize myocardial health.

AB - Context: Individuals with HIV have an elevated risk for developing cardiovascular disease compared to controls, particularly in relationship to abnormal deposition of lipid within various body compartments. Dysregulation of lipolysis may contribute to abnormal deposition of lipid in nonadipose tissues such as the heart, leading to untoward health consequences. Objective: To evaluate potential relationships between rates of whole-body lipolysis and intramyocardial lipid content in HIV-infected subjects compared to healthy controls. Design: Cross-sectional study. Setting: National Institutes of Health Clinical Research Center in Bethesda, Maryland. Participants: Forty-six HIV-infected adults and 12 controls without known cardiovascular disease. Main Outcome Measure: Intramyocardial lipid content quantified by MRI and rates of lipolysis determined using stable isotope tracer techniques. Results:Weobserved a significant positive correlation between the rate of appearance of glycerol and intramyocardial lipid overall (r = 0.323; P = .014) and among the HIV group separately (r = 0.361; P = .014). Multivariate regression analyses including HIV, lipid-lowering therapy, and diabetes identified both rate of appearance of glycerol and age as independent significant predictors of intramyocardial lipid (P = .01 and P = .03, respectively), but these were not significant with inclusion of visceral adipose in the analyses. Conclusions: To our knowledge, this study is among the first in humans to characterize the relationship between lipid deposition in the myocardium and direct measurement of whole-body fatty acid metabolism. Our current findings contribute to the growing understanding of factors that promote myocardial steatosis, such as visceral adiposity, and implicate lipolysis as a potential target for interventions to optimize myocardial health.

UR - http://www.scopus.com/inward/record.url?scp=84954543619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954543619&partnerID=8YFLogxK

U2 - 10.1210/jc.2015-3058

DO - 10.1210/jc.2015-3058

M3 - Article

C2 - 26555936

AN - SCOPUS:84954543619

VL - 101

SP - 151

EP - 156

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -